全文获取类型
收费全文 | 5845篇 |
免费 | 247篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 133篇 |
儿科学 | 231篇 |
妇产科学 | 260篇 |
基础医学 | 787篇 |
口腔科学 | 64篇 |
临床医学 | 433篇 |
内科学 | 1456篇 |
皮肤病学 | 75篇 |
神经病学 | 484篇 |
特种医学 | 75篇 |
外科学 | 392篇 |
综合类 | 37篇 |
一般理论 | 1篇 |
预防医学 | 468篇 |
眼科学 | 184篇 |
药学 | 631篇 |
中国医学 | 11篇 |
肿瘤学 | 397篇 |
出版年
2024年 | 7篇 |
2023年 | 46篇 |
2022年 | 154篇 |
2021年 | 240篇 |
2020年 | 94篇 |
2019年 | 120篇 |
2018年 | 141篇 |
2017年 | 136篇 |
2016年 | 157篇 |
2015年 | 155篇 |
2014年 | 219篇 |
2013年 | 267篇 |
2012年 | 435篇 |
2011年 | 478篇 |
2010年 | 256篇 |
2009年 | 203篇 |
2008年 | 339篇 |
2007年 | 425篇 |
2006年 | 399篇 |
2005年 | 391篇 |
2004年 | 400篇 |
2003年 | 367篇 |
2002年 | 328篇 |
2001年 | 22篇 |
2000年 | 18篇 |
1999年 | 20篇 |
1998年 | 32篇 |
1997年 | 31篇 |
1996年 | 20篇 |
1995年 | 25篇 |
1994年 | 10篇 |
1993年 | 8篇 |
1992年 | 13篇 |
1991年 | 11篇 |
1990年 | 6篇 |
1989年 | 10篇 |
1988年 | 7篇 |
1987年 | 8篇 |
1986年 | 7篇 |
1985年 | 8篇 |
1984年 | 11篇 |
1983年 | 12篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1975年 | 9篇 |
1974年 | 8篇 |
1972年 | 4篇 |
排序方式: 共有6119条查询结果,搜索用时 0 毫秒
71.
72.
Anna Szumera‐Ciekiewicz Grzegorz Rymkiewicz Kamil Sok Ewa Paszkiewicz‐Kozik Anita Borysiuk Jan Poleszczuk Katarzyna Bachnio Zbigniew Bystydzienski Renata Woroniecka Beata Grygalewicz Martyna Kotarska Monika Staczak Daria Owczarek Beata Pytlak Monika Prochorec‐Sobieszek Jan Walewski 《International journal of laboratory hematology》2020,42(4):453-463
73.
Jacek Karamon Maciej Kochanowski Jacek Sroka Tomasz Cencek Mirosław Różycki Ewa Chmurzyńska Ewa Bilska-Zając 《Parasitology research》2014,113(1):317-322
The aim of the study was to determine the prevalence of Echinococcus multilocularis in red foxes (Vulpes vulpes) in Poland. Overall, 1,546 intestinal samples from 15 of the 16 provinces in Poland were examined by the sedimentation and counting technique (SCT). The mean prevalence of E. multilocularis in Poland was 16.5 % and was found in 14 of the 15 examined provinces. The mean intensity of infection was 2,807 tapeworms per intestine. Distinct differences in prevalence were observed between regions. In some provinces of eastern and southern Poland, the level of prevalence was 50.0 % (Warmińsko-Mazurskie), 47.2 % (Podkarpackie), 30.4 % (Podlaskie) and 28.6 % (Ma?opolskie), while in other provinces (west and south-west), only a few percent was found: 2.0 % (Dolno?l?skie), 2.5 % (Wielkopolskie) and 0.0 % (in Opolskie). The border between areas with higher and lower prevalence seems to coincide with a north–south line running through the middle of Poland, with prevalence from 17.5 to 50.0 % in the eastern half and from 0.0 to 11.8 % in the western half. The dynamic situation observed in the prevalence of this tapeworm indicated the necessity of continuing to monitor the situation concerning E. multilocularis in red foxes in Poland. 相似文献
74.
Anna Nasulewicz‐Goldeman Waldemar Goldeman Ewa Mrwczyska Joanna Wietrzyk 《Chemical biology & drug design》2019,94(4):1835-1848
Nitrogen‐containing bisphosphonates (N‐BPs) inhibit bone resorption by preventing osteoclast activity. Most clinically used BPs are hydroxybisphosphonates with the exception of incadronate, which belongs to the class of aminomethylidenebisphosphonic acids. The aim of this study was to evaluate the antiproliferative activity of two previously reported aminobisphosphonates (WG8185B2 and WG9001B) in combination with doxorubicin and cisplatin toward J774E cells (a model of osteoclast precursors in vitro). WG8185B2 and WG9001B BPs enhanced the cytotoxic activity of doxorubicin and cisplatin, especially when applied 24 hr prior to cytostatics. The antiproliferative effect of studied BPs was related to the changes in cell cycle progression. WG8185B2 leads to significant accumulation of J774E cells in S phase, whereas WG9001B causes transient arrest in G2/M phase, followed by an increase in the percentage of cells in S phase. Moreover, WG8185B2 and WG9001B BPs showed enhanced proapoptotic activity in osteoclast precursors, which was manifested by an increase in caspase‐3 activity and percentage of apoptotic cells. In addition, both compounds influenced the motility of J774E cells. The exact molecular mechanism of action of examined BPs remains to be determined; however, results show an interesting biological activity of these compounds, which may be of interest in the context of antiresorptive therapy. 相似文献
75.
Karin G. Stenkula Maria Lindahl Jitka Petrlova Jonathan Dalla-Riva Olga Göransson Samuel W. Cushman Ewa Krupinska Helena A. Jones Jens O. Lagerstedt 《Diabetologia》2014,57(4):797-800
Aims/hypothesis
Apolipoprotein A-I (apoA-I), the main protein constituent of HDL, has a central role in the reverse cholesterol-transport pathway, which together with the anti-inflammatory properties of apoA-I/HDL provide cardioprotection. Recent findings of direct stimulation of glucose uptake in muscle by apoA-I/HDL suggest that altered apoA-I and HDL functionality may be a contributing factor to the development of diabetes. We have studied the in vivo effects of short treatments with human apoA-I in a high-fat diet fed mouse model. In addition to native apoA-I, we investigated the effects of the cardioprotective Milano variant (Arg173Cys).Methods
Male C57Bl6 mice on a high-fat diet for 2 weeks that received a single injection of human apoA-I proteins (wild-type and Milano) were analysed for blood glucose and insulin levels during a 3 h incubation followed by glucose tolerance tests. Incorporation of injected human apoA-I protein into HDLs was analysed by native gel electrophoresis.Results
ApoA-I treatment significantly improved insulin secretion and blood glucose clearance in the glucose tolerance test, with an efficiency exceeding that of lean control animals, and led to decreased basal glucose during the 3 h incubation. Notably, the two apoA-I variants triggered insulin secretion and glucose clearance to the same extent.Conclusions/interpretation
ApoA-I treatment leads to insulin- and non-insulin-dependent effects on glucose homeostasis. The experimental model of short-term (2 weeks) feeding of a high-fat diet to C57Bl6 mice provides a suitable and time-efficient system to unravel the resulting tissue-specific mechanisms of acute apoA-I treatment that lead to improved glucose homeostasis. 相似文献76.
77.
78.
79.
80.